Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-23T08:35:29.930Z Has data issue: false hasContentIssue false

Index

Published online by Cambridge University Press:  23 May 2024

Gloria HY Wong ,
Bosco HM Ma ,
Maggie NY Lee  and
David LK Dai
Gloria HY Wong
Affiliation:
The University of Hong Kong
Bosco HM Ma
Affiliation:
Hong Kong Alzheimer's Disease Association
Maggie NY Lee
Affiliation:
Hong Kong Alzheimer's Disease Association
David LK Dai
Affiliation:
Hong Kong Alzheimer's Disease Association

Summary

A summary is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Chapter
Information
Casebook of Dementia
A Reference Guide for Primary Care
 , pp. 250 - 256
Publisher: Cambridge University Press
Print publication year: 2024
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This content is Open Access and distributed under the terms of the Creative Commons Attribution licence CC-BY-NC-ND 4.0 https://creativecommons.org/cclicenses/

Index

abstract thinking. See cognition, abstract thinking.
abulia, 6
abuse, 226, 227
acetylcholinesterase inhibitors, 10
donepezil, 33–36, 43–44, 96, 112, 132–133, 179–181, 187
galantamine, 10, 220
rivastigmine, 10, 39–40, 42, 65, 125, 155, 164, 173
activities of daily living (ADL), 24–26, 173, 175, 178, 184–185, 186, 215–218
bathing, 32–34, 52–53, 59, 79, 81, 83, 133, 135
dressing, 24, 28, 30, 66, 71, 179, 183, 196
mobility, 7, 66, 68, 123, 179–181, 183, 185, 202, 203
toileting, 7, 9, 13, 120, 123, 126, 198, 202 See also incontinence.
transferring, 66, 179, 202, 203
wayfinding, 91, 114, 115, 143–144, 159, 183 See also instrumental activities of daily living.
adjustment disorder, 36, 46, 48, 73, 166, 239
advance care planning. See care planning.
aggression, 29, 203–204, 213, 238
agitation, 10, 29, 229, 238
alcohol use, 7, 188, 189, 212, 242
alexia, 6
allopurinol, 51, 57, 124
Alzheimer’s disease
aetiology, 6
age of onset, 113
comorbidities. See comorbidities.
diagnosis, 8, 15, 32
cognitive tests, 46, 48, 55 See also cognitive function.
differential diagnosis, 50, 112, 153, 182, 197, 213
early detection, 13
imaging, 100
symptom presentation, 25, 34, 43, 59, 106, 118–119
neuropathology, 6, 55
amyloid plaques, 6, 32, 54, 55, 69, 71, 112, 114
frontal lobe, 67, 110, 164, 171, 191
hippocampal sclerosis, 32, 94, 110
prevalence, 5
progression, 8, 9, 12–13, 63, 115
severe stage, 34, 36
risk factors, 98, 115
cardiovascular, 23, 114
cerebral, 42
Alzheimer’s Disease International (ADI), 1, 10, 220, 237
ambulation. See mobility.
amlodipine besylate, 57, 102, 108, 162, 164, 169, 173, 174
amyloid cascade hypothesis, 6
amyloid plaques, 6, 137, 144, 153, 170, 177
cerebral load, 48, 63, 69, 71, 73, 131, 137, 144
cognitive reserve against, 54, 55, 69
deposition, 170
hippocampal sclerosis and, 32, 94
imaging for, 114
anaemia, 84
antidepressants, 77, 164, 187, 194
antipsychotics, 30, 32, 34, 61, 63, 205, 237, 238
anxiety, 40, 42, 46, 90, 135, 136, 166, 187
apraxia, 81, 83, 127, 191, 209–214, 226, 234
aspirin, 98, 110, 138, 164, 169, 173, 194
asthma, 79–80, 106
atrial fibrillation, 45–46, 56, 94, 96–126, 130, 132, 162
attention deficit, 6, 24, 36, 75, 96–97, 113–114, 186, 201–202
Barthel Index, 24, 25–26, 36–38, 43, 50–53, 68–70, 73–75, 81–83
basal ganglia, 6, 110, 173
bathing, 32–34, 52–53, 59, 79, 81, 83, 133, 135
bed/chair transfers, 66, 179, 202, 203
behavioural dysfunction, 66–67, 135, 189, 191, 196–198, 230, 231, 238–239
aggression, 29, 203–204, 213, 238
agitation, 10, 29, 229, 238
disinhibition, 6, 214, 238
hoarding, 7, 197, 239
behavioural dysfunction, overeating, 29, 66–67, 120, 178–179, 213, 214
biopsychosocial model, 11, 149, 218, 239
bladder incontinence. See urinary incontinence.
blood assays
complete blood picture, 45, 47, 92, 96, 108, 171, 173
ESR (erythrocyte sedimentation rate), 41, 60, 92, 96, 110, 138, 149, 216
TSH (thyroid-stimulating hormone), 45, 96, 149, 150, 152, 154, 156, 173
blood pressure, 72, 136, 138, 166
bowel control, 73, 159, 179, 196, 202
bradycardia, 94, 195–196
bradykinesia, 6, 50, 199, 213
brain imaging. See imaging.
brain insulin resistance, 115
brain reserve, 170 See cognitive reserve.
bronchiectasis, 31
Calcichew, 49, 108, 138
cancer, 104, 162, 174
care homes, 123, 226
care planning, 10–14, 55, 57, 83, 106, 119, 225–228
Certified Dementia Care Planner, 10, 14
integrated care, 10, 13
carers, 4, 23, 30, 108, 111, 112, 176, 229–231, 234–236, 246–247
assessment by, 71, 75, 123, 129
community care and, 4
delusions involving, 34, 110
domestic assistance, 34, 77, 170, 172–173, 180, 188, 194, 207–208
family members as, 50–52, 54, 77, 226, 230, 231–233, 238–241
preparation for deterioration, 44, 191
primary care and, 15, 23, 24, 86
prompting by, 34, 88
reports by, 23, 27, 71, 191, 236
skills and education, 30, 50, 52, 82–83, 86, 104, 111, 203
communication skills, 34, 36, 44, 117, 137, 172, 233
preparation for deterioration, 44, 191
specialist care and, 4, 13
well-being and support of, 2, 10–12, 199, 209
stress, 102, 170, 189, 204, 210–212, 225, 229–230, 231
care services and resources, 237, 240
community centres, 4, 38, 100, 132, 142, 162
day care, 11, 52, 133, 168, 198, 199
social support networks, 57, 59, 73, 166, 215, 229
social workers, 4–5, 13, 46, 79, 81, 117–119, 131, 186–188
technology
location-tracking devices, 26, 30, 38, 48, 65, 79, 97, 100
carotid bruit, 84, 130, 132, 162, 171, 197
cataract, 25, 66, 68, 109, 110, 145, 149, 156
CBD. See cortobasical degeneration.
CBP. See complete blood picture.
CDR. See Clinical Dementia Rating.
cerebral atrophy, 52, 82, 88, 106, 108, 110, 124, 127
cerebral infarction, 187
cerebrovascular accident, 40–42, 126, 169–170, 173, 179–180, 182, 202
cervical myelopathy, 124
chlordiazepoxide, 169
cholinesterase inhibitors, 23, 63, 77, 92–93, 94, 127, 156, 184
chronic illnesses, 64, 80, 236
circadian cycle. 26, 48 See also sleep.
Clinical Dementia Rating (CDR), 8, 47–72, 75–76, 96–97, 139–141, 217, 219
mild dementia, 49, 118
moderate dementia, 53, 58, 60, 62, 118, 150, 188, 200
questionable dementia, 45
Clock Drawing Test, 24
clock copying section, 61, 63, 65, 70, 71–73, 161, 163, 165
not completed, 24, 65, 77, 79, 80, 148, 150
executive element impairment, 24, 25–26, 30–31, 34, 36, 61, 63, 65
no impairment, 24, 29, 47, 48, 139, 163, 172, 180
interlocking pentagon task and, 92, 100
sensitivity, 38
significant impairment, 28, 32, 42, 56, 58, 61, 81, 93
slight impairment, 24, 28, 50, 84, 123, 137, 139
time denotation, 36, 38, 40, 91, 93, 139–163, 165
clopidogrel, 134
clothing, 28, 30, 49, 51, 63–64, 66, 120–121, 126 See also dressing.
cognitive function
abstract thinking, 9, 63, 71, 145, 146, 183, 186, 191
ADL function and
dissociation, 59
attention deficit, 6, 24, 36, 75, 96–97, 113–114, 186, 201–202
cognitive frailty, 75, 112, 146, 153, 175, 192, 194–195, 201
deterioration, 34, 36, 55, 73, 78, 92, 201, 206
executive function, 6, 7, 22–24, 63–64, 108–109, 145–146, 166–168, 170
naming, 22, 145, 146, 183, 186, 191
screening tests, 7, 36, 46, 52, 55, 209, 212, 216–218
cognitive reserve, 54, 55, 114, 115, 119, 131, 210, 215
cognitive stimulation therapy (CST), 10, 160, 233, 237–238
cognitive tests. See cognitive function, screening tests.
colchicine, 57
community care, 75–77, 79, 81, 99, 101–102, 133, 240–242, 247
community centres, 4, 38, 100, 132, 142, 162
community engagement (of patient), 9, 49–50, 76, 101, 122, 141, 167, 168
comorbidities, 6, 12, 53–54, 178, 239
anaemia, 83, 84
cardiovascular conditions, 39
chronic illnesses, 80, 236
depression, 4, 46, 61, 89
urinary tract infection, 96
vascular dementia, 46, 57 See also mixed dementia.
complete blood picture, 45, 47, 92, 96, 108, 171, 173
computed tomography. See CT.
conduction dysphasia, 182
Cornell Scale for Depression in Dementia, 55
corticobasal degeneration, 126–127, 213–214
counselling, 14, 36, 46, 227, 232
CT (computed tomography imaging), 41–42, 59, 60, 88, 177, 182, 190–191, 215–216
daily living activities. See activities of daily living.
day care, 48, 50, 52, 71, 72–73, 74, 132–133, 167–168
deafness. See hearing impairment.
delayed recall, 34, 38, 42–44, 105–107, 135, 139–141, 149–150, 174–175
delirium, 147, 171, 192, 209, 213, 239
delusions, 31–35, 60–63, 89–91, 107–114, 116–118, 153–154, 169–172
defined, 212
depression, 45–47, 58–170, 184–188
assessments in case studies, 45, 46, 57, 76, 89–91
carer stress and, 142
IADL dependency and, 42
pharmacological interventions, 77, 102, 164, 187, 194
prevalence, 219
as pseudodementia, 7
as risk factor, 92
suicidal ideation and, 101
Describe, Investigate, Create, Evaluate (DICE) model, 238
diabetes, 90–92, 98, 115, 173, 174, 177, 178, 239
dialectic model, 11
diazoxide, 174
diet, 34, 35, 59, 61, 84, 86, 113, 177–179
digoxin, 57, 94, 96
disinhibition, 6, 214, 238
disorientation, 24, 32, 35, 57, 61, 95, 199–200, 202
distressed behaviours, 40, 196, 201, 204, 229, 230, 238
DLB. See Lewy body dementia.
donepezil, 33–36, 43–44, 96, 112, 132–133, 179–181, 187
dressing, 24, 28, 30, 66, 71, 179, 183, 196
drinking. 7 See alcohol use.
dyslipidaemia, 98, 106, 124, 126, 162, 164, 169, 173
early dementia, 15, 50, 70, 81, 87, 108, 177, 213–214
early detection services, 13, 209, 215, 216, 218, 231, 234, 241
EDS (Hong Kong), 13–15
early intervention services, 1, 4–13, 83, 84, 209, 215, 220
end-of-life care, 209, 228
enduring power of attorney (EPA/EPOA), 13, 191, 227
escitalopram, 135, 187, 194
esomeprazole, 115
ESR (erythrocyte sedimentation rate), 41, 60, 92, 96, 110, 138, 149, 216
executive function, 6, 7, 22–24, 63–64, 108–109, 145–146, 166–168, 170
exercise (physical), 10, 27–28, 31–32, 34, 59, 86, 231, 238
family care. See carers.
famotidine, 45, 88, 171
fasting lipids profile, 45, 47–98, 124, 127, 171, 173
fasting sugar profile, 94, 96–173, 202–203
FAST. See Functional Assessment Staging.
flupentixol, 169
forgetfulness. See memory impairment.
frailty, 75, 110, 125, 127, 153, 157, 194, 234–236
frontal lobe pathology, 67, 110, 164, 171, 191
frontotemporal dementia (FTD), 6–7, 8, 15, 179, 190–191, 204, 208, 213–214
Functional Assessment Staging (FAST), 8, 12, 129, 151, 209, 219, 226
gait abnormalities. 6, 123, 130, 132, 162, 171 See also ambulation; mobility.
galantamine, 10, 220
gaze palsy, 50
GDS. See Global Deterioration Scale.
General Practitioner Assessment of Cognition. See GPCOG.
glaucoma, 145, 149
Global Action Plan on the Public Health Response to Dementia 2017–2025, 2, 220
Global Deterioration Scale, 8, 217, 219
goitre, 45
gout, 23, 29, 31, 56, 74, 78, 86, 124
GPCOG Informant Interview, 211–212
grocery shopping. See shopping.
hallucinations, 6, 10, 123, 125, 172, 189, 199–201, 213 See also delusions.
head injury, 98–99, 212, 216
hearing impairment, 47, 138–139, 150–151, 204, 215, 242
heart disease, 60, 98, 124, 138, 156, 169
hippocampal sclerosis, 32, 94, 110
hip replacement, 25, 33, 45, 202, 239
hoarding, 7, 197, 239
hobbies, 74, 97, 99, 103, 105, 122, 143–144
home care, 3, 11–13
home modifications, 12, 100, 166
home safety, 4, 129, 166, 225
household tasks, 26, 95, 107, 129, 136, 198, 201
housekeeping, 24–26, 51, 53, 58, 60, 73, 117
hygiene
environmental, 65, 68, 126, 139
personal, 6, 120, 126–131, 139, 196–197, 214, 239
hypercholesterolaemia, 115, 116, 177, 178, 180, 182, 202, 204
hyperlipidaemia, 56, 90, 188
hyperorality, 7
hyperplasia, 31, 80, 118, 124, 174, 196–197, 199, 204
hypertension, 29, 31, 66, 72–150
hypotension, 6, 195–196
hysterectomy, 88, 173
ICD-11, 8
imaging, 3, 8, 46, 100, 191, 196, 208, 216
CT (computed tomography), 41–42, 59, 60, 88, 177, 182, 190–191, 215–216 See also magnetic resonance imaging(MRI)
X-ray, 3
incontinence, 198, 214
bowel control, 73, 159, 179, 196, 202
urinary, 6, 47, 73, 89, 96–97, 126, 196, 202
independence, 69, 78–79, 83–85, 110, 129, 142, 144, 146
insomnia. See sleep.
Instrumental Activities of Daily Living (IADL), 218
aids and support
reminders, 26, 85, 127–129, 137, 153–155, 159, 163–164, 197–198
assessment tools, 218
grocery shopping, 24–26, 36, 38, 58, 60, 64, 66, 68
laundry, 24, 26, 51, 53, 58, 60, 73, 75
meal preparation, 24, 28, 47, 49, 58, 60, 87, 193–195
medication management, 47, 104, 125, 211, 234
integrated care, 10, 13
ipratropium bromide, 80, 124
irritability. See also aggression, 29, 61, 90, 91, 123, 164, 189–191, 207
isosorbide dinitrate, 96
isosorbide mononitrate, 124, 138
language impairment, 34, 38, 54–55, 81–83, 100–101, 121–125, 190–191, 207–208
laundry, 24, 26, 51, 53, 58, 60, 73, 75
Lewy body dementia, 6, 8, 10, 50, 125, 199, 200, 213
life events, 11–12, 233
lifestyle factors, 52, 54, 179, 242
alcohol use, 7, 188, 189, 212, 242
smoking, 7, 215, 242
living tasks. See activities of daily living (ADL).
location-tracking devices, 26, 30, 38, 48, 65, 79, 97, 100
low motivation, 52, 77, 87, 92, 109, 133, 163, 172
magnetic resonance imagine (MRI), 45–46, 47, 106, 113, 140, 169, 205–206, 215–216
meal preparation, 24, 28, 47, 49, 58, 60, 87, 193–195
mecobalamin, 84, 163
medial lateral temporal atrophy, 57, 82, 140, 171
mediastinum, 138
memantine, 55, 59, 61, 179, 181, 182, 184, 237
memory clinics, 3–5, 13, 92
memory impairment, 47, 48, 71, 72–161
Alzheimer’s disease
early stage, 8
carer concerns, 72–129
delayed recall, 34, 38, 42–44, 105–107, 135, 139–141, 149–150, 174–175
deterioration, 79, 117, 125, 129, 166, 168
family reported, 22–24, 59–81, 89–91
IADL and, 51
Lewy body dementia, 6
masking, 110
misplacement of belongings, 121, 139, 141, 144
patient insight, 48
meningioma, 110, 206
mental health, 147, 196, 212, 229, 239–240
anxiety, 40, 42, 46, 90, 135, 136, 147, 166, 187 See also depression.
suicidal ideation, 101, 102, 189, 227
metformin, 92, 98–99, 124, 126, 162–163, 173
methotrexate, 49
methyldopa, 185–186
metoprolol succinate, 169, 173
mild cognitive impairment (MCI), 7–19, 153, 162, 164, 168, 173, 175, 177
mild dementia, 41, 47, 49, 118, 145–146, 159–160, 176–177
Mini-Mental State Examination. See MMSE.
mixed dementia, 61, 88, 102, 127, 182, 203, 237
MMSE (Mini-Mental State Examination), 168, 191, 216–217, 234
interlocking pentagon task, 34, 38, 90, 92, 99, 100, 158, 160
mobility, 66, 68, 123, 179–181, 183, 185, 202, 203
moderate Alzheimer’s disease, 9, 29, 70–71, 76, 78, 83, 234, 237
moderate cognitive impairment, 123
moderate dementia, 4, 10, 28, 30, 35, 40, 66
Montreal Cognitive Assessment (MoCA), 145, 146, 147, 155–156, 161–162, 168, 170, 217–218
mood change. 46–47, 56–58, 76–77, 89–90, 92–95, 99–103, 107–110, 185–186 See also depression.
morphine, 138
Multispecialty Interprofessional Teams, 4
naming, 22, 145, 146, 183, 186, 191
National Dementia Strategy, 3
neurofibrillary tangles, 6
neuroimaging. See imaging.
neuroleptics, 90, 172, 237
Neuropsychiatric Interview Questionnaire, 55
NICE (National Institute for Health and Care Excellence), 5, 215, 220, 237, 240
non-Alzheimer’s dementia, 29, 31, 35, 37, 43, 45, 49, 213–214
non-pharmacological interventions, 10–11, 12, 23–24, 30, 32, 40, 112, 237
object agnosia, 6
obstructive pulmonary disease, 80, 96, 124
occupational therapists, 4–5, 10, 13, 144
old age, extreme, 32
osteoarthritis, 23, 88, 173, 195, 204
osteoporosis, 45, 138, 156
overeating, 29, 66, 120, 178–179, 213, 214
palliative care. See end-of-life care.
pancytopenia, 31
pantoprazole, 49, 94, 98, 102, 110, 126, 156, 164
paracetamol, 126, 171
Parkinson disease dementia (PDD), 10, 50, 213
parkinsonism, 6, 50, 125, 189, 198–199, 213–214
atypical, 50
bradykinesia, 6, 50, 199, 213
pepcidine, 169
personal care. 9, 72, 74, 76, 101, 167 See also activities of daily living (ADL).
personality change, 6, 11, 32, 100, 133, 206–208, 229, 231
person-centred care, 2, 5, 11, 15, 40, 226, 238
PET (positron emission tomography), 6, 177
physical exercise, 10, 238
power of attorney (EPA/EPOA), 13, 191, 227
primary care, 1–18, 62–81, 84–110, 147–175
carers and, 236
diagnostic accuracy, 15
key considerations, 232, 237
models, 3, 11
with specialist outreach, 3
prescribing, 10
resources for, 212
roles, 11–12, 15
service integration, 5, 12
specialist care and, 3
primary progressive aphasia (PPA), 8, 96, 213–214
pseudobulbar palsy, 6
pseudodementia. See depression.
psychiatric disorders. 31, 33, 35, 37, 43, 45, 49, 51 See also depression; mental health.
psychoeducation, 36, 46, 102, 106, 229–230
psychomotor retardation, 6
psychotherapy, 46, 92, 188
public awareness, 59, 153, 241
Quality and Outcomes Framework, 3
quetiapine, 30, 63, 125, 188–189
radiation therapy, 162
rapid eye movements behaviour disorder (REMBD), 6, 125, 172, 189, 199, 213
reminders, 26, 85, 127–129, 137, 153–155, 159, 163–164, 197–198
residential care. See care homes.
resistance to care, 52, 238
Resources for Enhancing Alzheimer’s Carer Health, 10
rigidity, 6, 104, 213, 237
risk factors, 114, 242
cardiovascular, 7, 23, 114, 115, 177, 180, 239, 242
cerebral, 42, 84
chronic disease, 92
diabetes, 42, 115 See also comorbidities.
rivaroxaban, 57
rivastigmine, 10, 39–40, 42, 65, 125, 155, 164, 173
safety, 10, 30, 38, 121, 129, 209, 210, 215
salbutamol, 80, 124
screening tests. 7 See cognitive screening tests.
secondary care, 4, 14–15, 102, 104, 208
selective serotonin reuptake inhibitors (SSRI), 67, 90, 102, 108, 135, 171, 197
self-awareness, 55, 73, 106, 108, 163, 166, 206
self-care, 31, 34, 35, 66–67, 69, 82–83, 126–127, 213
shopping, 24–26, 30, 36, 38, 60, 64, 66, 87
simvastatin, 45, 57, 98, 102, 124, 126, 173, 194
sleep, 6, 93, 94, 134, 137, 189, 198–199, 201
small vessel disease, 47, 84, 85–87, 88, 92, 110, 115, 184
smoking, 7, 215, 242
social centres, 11
social interaction, 35, 59, 61, 84, 113, 144, 182–183, 237–238
social workers, 4–5, 13, 46, 79, 81, 117–119, 131, 186–188
specialist care, 1–5, 11, 13–14, 15, 204, 206, 232, 236–237
SSRIs. See selective serotonin reuptake inhibitors.
stress (carers), 86, 102, 117, 189, 204, 208, 212, 229
stroke, 6, 95–97, 127–131, 177, 179, 180–182, 203, 212–213
strontium ranelate, 169
subdural haematoma, 22–23, 98, 169, 216
subjective cognitive impairment, 7, 141, 155
suicidal ideation, 101–102, 189, 227
support services. See care and support services and resources.
swallowing problems, 13, 66, 214
Swedish Dementia Registry, 3
task-sharing, 1, 14–15
task-shifting, 1, 2, 14–15, 16
temper. See irritability.
temporal lobe degeneration, 57, 82–83, 110, 124
thalassemia, 197
thiamine, 189
three-step command task, 24, 30, 32, 42, 44, 51, 53, 56
thyroid function, 8
thyroid-stimulating hormone, 45, 96, 149, 150, 152, 154, 156, 173
toileting, 7, 9, 13, 120, 123, 126, 198, 202 See also incontinence.
transferring, 66, 179, 202, 203
tremor, 50, 124, 213
triage, 13, 81, 153, 156, 212, 218, 219, 234
United Kingdom, 3, 5, 209, 215, 236
urinary incontinence, 47, 73, 96–97, 126, 142, 159, 196, 202
utilisation behaviours, 6
valproate, 171, 197, 205
vascular dementia, 42, 96, 102, 106, 177–179, 181, 182, 184
verbal expression, 24, 26, 153, 155, 183–184, 191, 203, 204 See also word finding.
verbal function, naming, 22, 145, 146, 183, 186, 191
vildagliptin, 98, 173
visual hallucinations, 6, 50, 66, 160, 198–201, 213
visual impairment, 32, 154 See also cataract; glaucoma.
waiting times, 2, 5, 13–15
warfarin, 45, 96, 126
wayfinding, 91, 114, 115, 143–144, 159, 183
word finding, 23, 90–91, 109–110, 158–160, 180–182, 183, 190–191, 200–202 See also verbal expression; naming; GPCOG informant interview.
World Alzheimer’s Report, 1, 2, 13
X-ray, 127, 134, 138, 140, 158, 160, 166

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Index
  • Gloria HY Wong, The University of Hong Kong, Bosco HM Ma, Hong Kong Alzheimer's Disease Association, Maggie NY Lee, Hong Kong Alzheimer's Disease Association, David LK Dai, Hong Kong Alzheimer's Disease Association
  • Book: Casebook of Dementia
  • Online publication: 23 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781108989336.009
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Index
  • Gloria HY Wong, The University of Hong Kong, Bosco HM Ma, Hong Kong Alzheimer's Disease Association, Maggie NY Lee, Hong Kong Alzheimer's Disease Association, David LK Dai, Hong Kong Alzheimer's Disease Association
  • Book: Casebook of Dementia
  • Online publication: 23 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781108989336.009
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Index
  • Gloria HY Wong, The University of Hong Kong, Bosco HM Ma, Hong Kong Alzheimer's Disease Association, Maggie NY Lee, Hong Kong Alzheimer's Disease Association, David LK Dai, Hong Kong Alzheimer's Disease Association
  • Book: Casebook of Dementia
  • Online publication: 23 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781108989336.009
Available formats
×